Celadon securing contracts for supply of pharma-grade medicinal cannabis
Celadon Pharmaceuticals has today (December 14) announced its first supply of it pharmaceutical-grade breakthrough cannabis-based medicine.
Archives for December 14, 2023
Mission Therapeutics moves kidney disease drug to phase 2 after FDA approval
Mission Therapeutics, a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, has received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) to proceed with a phase 2 trial for its...
Deep Apple Therapeutics raises $52 million for small molecule therapeutics discovery
A portfolio company created and incubated by Apple Tree Partners (ATP) has raised $52 million in series A funding to enable it to rapidly discover novel small molecule therapeutics.
Atropos Health and SEQESTER partner to save time, money and accelerate drug development
Patient centric, healthcare data tech company, SEQESTER says it can now deliver real-time and real-world data layering in artificial intelligence (AI) to accelerate drug discovery, thanks to its partnership with Atropos Health.
Enrolment complete for Lindus Health and Thirty Madison's pilot dermatology study
UK-based Lindus Health and US-based Thirty Madison today (December 14) announced they have completed the enrolment of a trial to assess their personalized dermatology telemedicine platform, Facet.